Compare International Business Machines Corp (IBM) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
International Business Machines Corp vs Natera Inc. Common Stock — how do they compare? International Business Machines Corp trades at $228.3 (market cap $217.43B), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: International Business Machines Corp is far larger — about 3.8× Natera Inc. Common Stock's market cap, and International Business Machines Corp pays a 2.93% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 89 Days and Natera Inc. Common Stock for 0 Days on average.
| IBM | NTRA | |
|---|---|---|
Market Cap | $217.43B | $57.03B |
Volume | 5,119,486 | 1,131,157 |
Sector | Technology | Health |
52-Week High | $329.23 | $425.64 |
52-Week Low | $205.77 | $179.42 |
Typical Hold Time | 89 Days | 0 Days |
Enterprise Value | $274.57B | $56.18B |
Dividend Yield | 2.93% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBM stock trades at $230.78, up 1.66% with recent momentum driven by positive consulting sector sentiment and the launch of self-hosted deployment for its Bob AI platform. The company shows strong fundamentals with 2025 revenue of $67.54B and net income of $10.59B, though technical indicators signal bearish pressure. Recent earnings performance has been mixed with Q2 2026 missing expectations, while analyst consensus remains positive with a $255.50 price target.
IBM presents a balanced investment case with solid profitability metrics (15.52% net margin, 34.62% ROE) and growing AI consulting business ($5.5B book), but faces risks from cyclical mainframe weakness and competitive pressures. The stock trades at reasonable valuations (P/E 20.5) with upside potential if AI initiatives drive sustained growth.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About International Business Machines Corp
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
